持续皮下注射奥曲肽成功治疗一名接受血液透析的成年发病的胰岛细胞增殖症患者。
Successful treatment of adult-onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis.
作者信息
Kato Rina, Nishimura Akihiro, Matsumura Kimio, Kikuno Shota, Nagasawa Kaoru, Mori Yasumichi
机构信息
Department of Endocrinology and Metabolism Toranomon Hospital Minato-ku Japan.
出版信息
Clin Case Rep. 2020 Nov 11;9(1):278-281. doi: 10.1002/ccr3.3514. eCollection 2021 Jan.
Abstract
Octreotide may be useful in noninsulinoma pancreatogenous hypoglycemia syndrome with nesidioblastosis patients who was on hemodialysis. Continuous octreotide subcutaneous infusion can reduce side-effects and stabilize plasma glucose levels.
摘要
奥曲肽可能对患有胰岛细胞增殖症的非胰岛素瘤胰腺源性低血糖综合征且正在接受血液透析的患者有用。持续皮下输注奥曲肽可减少副作用并稳定血糖水平。
Zotero 插件